US2023075305A1PendingUtilityA1

Platform and method for tokenizing dna data

73
Assignee: DATA VAULT HOLDINGS INCPriority: Sep 9, 2021Filed: Sep 9, 2022Published: Mar 9, 2023
Est. expirySep 9, 2041(~15.2 yrs left)· nominal 20-yr term from priority
G06Q 40/10G06Q 50/02G06Q 40/04G06Q 20/382G06Q 30/0208G06Q 30/0206G16H 50/30G16B 30/00G06Q 20/38215G06Q 30/0214G06Q 2220/00G06Q 20/389G06Q 20/065H04L 9/50G06Q 20/3827G16H 10/40H04L 9/3213G06Q 30/0241G06Q 10/0637G06Q 30/0234G06Q 30/0645G16H 40/67G16H 10/60G16H 40/20G06Q 30/0215G06Q 30/0236G06Q 30/06G06Q 30/0201H04L 2209/60G06Q 20/3672
73
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A system, method, device, and data platform for managing DNA data utilizing tokens. DNA data associated with a user is obtained. The DNA data is stored in a DNA profile associated with the user by a data platform. The DNA data is tokenized into one or more tokens. The DNA data is monetized.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A method for managing deoxyribonucleic acid (DNA) data utilizing tokens, comprising:
 obtaining DNA data associated with a user, the DNA data is stored in a DNA profile associated with the user by a data platform;   tokenizing the DNA data into one or more tokens; and   monetizing the DNA data.   
     
     
         2 . The method of  claim 1 , further comprising:
 generating each of the one or more tokens associated with the DNA data, wherein the one or more tokens are blockchain tokens saved in a digital ledger, and wherein the one or more tokens are linked to the associated DNA data that is securely stored.   
     
     
         3 . The method of  claim 1 , further comprising:
 sampling DNA from the user; and   processing the DNA to generating the DNA data.   
     
     
         4 . The method of  claim 1 , further comprising:
 analyzing the DNA data to determine at least types of data and amounts of data included within the DNA data.   
     
     
         5 . The method of  claim 1 , further comprising:
 valuing the DNA data;   determining potential monetization strategies for the DNA data; and   presenting the monetization strategies to the one or more corporations.   
     
     
         6 . The method of  claim 1 , further comprising:
 determining traits, defects, and risks for developing medical conditions.   
     
     
         7 . The method of  claim 1 , wherein the monetization strategies include at least selling the DNA data, leasing the DNA data, and providing the DNA data without identifying information regarding individuals or corporations. 
     
     
         8 . The method of  claim 1 , further comprising:
 creating a smart contract controlling utilization of the DNA data if and when monetized.   
     
     
         9 . The method of  claim 1 , further comprising:
 deidentifying the DNA data so that the user is unidentifiable from the one or more tokens.   
     
     
         10 . The method of  claim 1 , further comprising:
 advertising the DNA data to authorized parties; and   performing transactions for the one or more tokens associated with the DNA data.   
     
     
         11 . A system for managing DNA data, comprising:
 a DNA system for determining DNA data associated with a user;   a plurality of electronic devices executing a data application, the data application is configured to capture the information associated with a user; and   a data platform in communication with the DNA system and accessible by the plurality of electronic devices executing the data application through one or more networks, wherein the data platform tokenizes the DNA data and the information into one or more tokens, and monetizes the DNA data, wherein the DNA data is stored in a DNA profile associated with the user.   
     
     
         12 . The system of  claim 11 , wherein the DNA system receives a DNA sample from the user, wherein the system includes a DNA sequencer. 
     
     
         13 . The system of  claim 11 , wherein the information and the DNA data is deidentified so that the user is unidentifiable from the one or more tokens, wherein the one or more tokens are blockchain tokens, and wherein the one or more tokens and associated DNA data are saved in a digital ledger. 
     
     
         14 . The system of  claim 11 , wherein the data platform further generates each of the one or more tokens associated with the DNA data, advertises the DNA data to authorized parties, and performs transactions for the one or more tokens associated with the DNA data. 
     
     
         15 . The system of  claim 11 , wherein the data platform further determines traits, defects, and risks for developing medical conditions. 
     
     
         16 . A data platform, comprising:
 a processor for executing a set of instructions;   a memory for storing the set of instructions, wherein the set of instructions are executed to:   determine information associated with a user;   obtain DNA data associated with a user, the information and the DNA data is stored in a DNA profile associated with the user by a data platform;   deidentifying the DNA profile so that the user is not identifiable through the information or the DNA data;   tokenize the DNA profile into one or more tokens; and   monetize the DNA data.   
     
     
         17 . The data platform of  claim 16 , further comprising:
 a DNA system that determines the DNA data from a DNA sample provided by the user.   
     
     
         18 . The data platform of  claim 16 , wherein the set of instructions are further executed to:
 analyze the DNA data to determine at least traits, defects, and risks for developing medical conditions.   
     
     
         19 . The data platform of  claim 16 , wherein the set of instructions generate each of the one or more tokens associated with the DNA data, advertise the DNA data to authorized parties, and perform transactions for the one or more tokens associated with the DNA data, wherein the one or more tokens are blockchain tokens, and wherein the one or more tokens and associated DNA data are saved in a digital ledger. 
     
     
         20 . The data platform of  claim 16 , further comprising:
 a gene sequencer configured to generate the DNA data from a specimen of the user.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.